These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 7223636)

  • 41. Zinc protoporphyrin, blood lead and clinical symptoms in two occupational groups with low-level exposure to lead.
    Fischbein A; Thornton JC; Lilis R; Valciukas JA; Bernstein J; Selikoff IJ
    Am J Ind Med; 1980; 1(3-4):391-9. PubMed ID: 6979248
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Establishment of normal values in adults for zinc protoporphyrin (ZPP) using hematofluorometer: correlation with normal blood lead values.
    Suga RS; Fischinger AJ; Knoch FW
    Am Ind Hyg Assoc J; 1981 Sep; 42(9):637-42. PubMed ID: 7293926
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Significance of erythrocyte protoporphyrin as a laboratory diagnostic parameter in lead exposed subjects].
    Töppich D; König R
    Z Med Lab Diagn; 1978; 19(3):193-4. PubMed ID: 695816
    [No Abstract]   [Full Text] [Related]  

  • 44. The fall of zinc protoporphyrin levels in workers treated for chronic lead intoxication.
    Hryhorczuk DO; Hogan MM; Mallin K; Hessl SM; Orris P
    J Occup Med; 1985 Nov; 27(11):816-20. PubMed ID: 3934354
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Central nervous system dysfunction due to lead exposure.
    Valciukas JA; Lilis R; Fischbein A; Selikoff IJ; Eisinger J; Blumberg WE
    Science; 1978 Aug; 201(4354):465-7. PubMed ID: 663669
    [TBL] [Abstract][Full Text] [Related]  

  • 46. ALAD/EP ratio as a measure of lead toxicity.
    Beritić T; Prpić-Majić D; Karacić V; Telisman S
    J Occup Med; 1977 Aug; 19(8):551-7. PubMed ID: 894378
    [No Abstract]   [Full Text] [Related]  

  • 47. Zinc protoporphyrin levels, blood lead levels and neurocognitive deficits in Andean children with chronic lead exposure.
    Counter SA; Buchanan LH; Ortega F
    Clin Biochem; 2008 Jan; 41(1-2):41-7. PubMed ID: 18035344
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Zinc protoporphyrin level in blood determined by a portable hematofluorometer: a screening device for lead poisoning.
    Blumberg WE; Eisinger J; Lamola AA; Zuckerman DM
    J Lab Clin Med; 1977 Apr; 89(4):712-23. PubMed ID: 557519
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Exposure of selected population groups to lead. III. Use of a rapid fluorometric screening method for determining zinc protoporphyrin (ZPP) after exposure to lead].
    Grabecki J; Jarkowski M
    Rocz Panstw Zakl Hig; 1984; 35(1):13-22. PubMed ID: 6718961
    [No Abstract]   [Full Text] [Related]  

  • 50. Erythropoietic protoporphyria and lead intoxication: the molecular basis for difference in cutaneous photosensitivity. II. Different binding of erythrocyte protoporphyrin to hemoglobin.
    Lamola AA; Piomelli S; Poh-Fitzpatrick MG; Yamane T; Harber LC
    J Clin Invest; 1975 Dec; 56(6):1528-35. PubMed ID: 1202083
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Selected biomarkers for evaluating occupational exposure to lead among workers from the "Miasteczko Slaskie" zincworks in Tarnowskie Gory].
    Kwapuliński J; Komosińska K; Wiechuła D; Kraśnicka A; Orczyk H
    Med Pr; 1995; 46(2):141-7. PubMed ID: 7637632
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Impairment of renal function with increasing blood lead concentrations in the general population. The Cadmibel Study Group.
    Staessen JA; Lauwerys RR; Buchet JP; Bulpitt CJ; Rondia D; Vanrenterghem Y; Amery A
    N Engl J Med; 1992 Jul; 327(3):151-6. PubMed ID: 1608406
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cost effectiveness of lead screening.
    Berwick DM; Komaroff AL
    N Engl J Med; 1982 Jun; 306(23):1392-8. PubMed ID: 6804866
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Erythrocyte protoporphyrin and blood lead levels of children from Jammu and Srinagar and papier mache trainees.
    Kaul PS; Kaul B
    Indian J Pediatr; 1986; 53(5):641-6. PubMed ID: 3817984
    [No Abstract]   [Full Text] [Related]  

  • 55. Use of zinc protoporphyrin in screening individuals for exposure to lead.
    Zwennis WC; Franssen AC; Wijnans MJ
    Clin Chem; 1990 Aug; 36(8 Pt 1):1456-9. PubMed ID: 2387041
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Subjective symptoms in workers with low-level exposure to lead.
    Fischbein A; Thornton JC; Sarkozi L; Kon S; Levin S
    J Appl Toxicol; 1982 Dec; 2(6):289-93. PubMed ID: 7185907
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Improved ethanol extraction procedure for determining zinc protoporphyrin in whole blood.
    Garden JS; Mitchell DG; Jackson KW; Aldous KM
    Clin Chem; 1977 Sep; 23(9):1585-9. PubMed ID: 890899
    [No Abstract]   [Full Text] [Related]  

  • 58. New ceramics-related industry implicated in elevated blood lead levels in children.
    Kaye WE; Novotny TE; Tucker M
    Arch Environ Health; 1987; 42(3):161-4. PubMed ID: 3606214
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Zinc protoporphyrin: a product of iron-deficient erythropoiesis.
    Labbe RF; Rettmer RL
    Semin Hematol; 1989 Jan; 26(1):40-6. PubMed ID: 2646724
    [No Abstract]   [Full Text] [Related]  

  • 60. Psychological dysfunctions in lead-exposed workers. Relation to biological parameters of exposure.
    Grandjean P; Arnvig E; Beckmann J
    Scand J Work Environ Health; 1978 Dec; 4(4):295-303. PubMed ID: 734390
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.